Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

72 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Carfilzomib, venetoclax and dexamethasone for relapsed/refractory multiple myeloma.
Boccon-Gibod C, Talbot A, Le Bras F, Frenzel L, Royer B, Harel S, Lombion N, Belhadj K, Cuccuini W, Arnulf B. Boccon-Gibod C, et al. Among authors: le bras f. Br J Haematol. 2020 May;189(3):e73-e76. doi: 10.1111/bjh.16483. Epub 2020 Feb 3. Br J Haematol. 2020. PMID: 32012229 Free article. No abstract available.
Venetoclax induces profound and sustained responses in patients with relapsed/refractory light-chain amyloidosis.
Pasquer H, Belhadj K, Dupuis J, Oghina S, Galat A, Ladaique A, Maarek A, Roulin L, Gounot R, Poulot E, Beldi-Ferchiou A, Molinier-Frenkel V, Haioun C, Damy T, Le Bras F, Lemonnier F. Pasquer H, et al. Among authors: le bras f. Br J Haematol. 2021 May;193(3):674-677. doi: 10.1111/bjh.17380. Epub 2021 Mar 13. Br J Haematol. 2021. PMID: 33713427 No abstract available.
Rituximab plus gemcitabine and oxaliplatin (R-GemOx) in refractory/relapsed diffuse large B-cell lymphoma: a real-life study in patients ineligible for autologous stem-cell transplantation.
Cazelles C, Belhadj K, Vellemans H, Camus V, Poullot E, Gaulard P, Veresezan L, Itti E, Becker S, Carvalho M, Dupuis J, Le Bras F, Lemonnier F, Roulin L, El Gnaoui T, Jardin F, Mounier N, Tilly H, Haioun C. Cazelles C, et al. Among authors: le bras f. Leuk Lymphoma. 2021 Sep;62(9):2161-2168. doi: 10.1080/10428194.2021.1901090. Epub 2021 Mar 25. Leuk Lymphoma. 2021. PMID: 33764240 Free article.
A prospective phase 2 trial of daratumumab in patients with previously treated systemic light-chain amyloidosis.
Roussel M, Merlini G, Chevret S, Arnulf B, Stoppa AM, Perrot A, Palladini G, Karlin L, Royer B, Huart A, Macro M, Morel P, Frenzel L, Touzeau C, Boyle E, Dorvaux V, Le Bras F, Lavergne D, Bridoux F, Jaccard A. Roussel M, et al. Among authors: le bras f. Blood. 2020 Apr 30;135(18):1531-1540. doi: 10.1182/blood.2019004369. Blood. 2020. PMID: 32108228 Free article. Clinical Trial.
Plasma cell-directed therapies in monoclonal gammopathy-associated scleromyxedema.
Mahévas T, Arnulf B, Bouaziz JD, Livideanu CB, Osio A, Servy A, Cribier B, Sassolas B, Jachiet M, Michel L, Aucouturier P, Lipsker D, Frances C, Sbidian E, Rybojad M, Descamps V, D'Incan M, Humbert P, Beylot-Barry M, Passeron T, de Moreuil C, Taha RY, Hermine O, Dupuy A, Barbarot S, Debarbieux S, Carpentier O, Brault F, Schmutz JL, Thomas-Beaulieu D, Modiano P, Zarnitsky C, Lifermann F, Baubion E, Limal N, Le Bras F, Le Moigne M, Tauber M, Talbot A, Prud'homme R, Peltier S, De Masson A, Battistella M, Bagot M, Mékinian A, Fain O. Mahévas T, et al. Among authors: le bras f, le moigne m. Blood. 2020 Apr 2;135(14):1101-1110. doi: 10.1182/blood.2019002300. Blood. 2020. PMID: 32027747 Free article.
Effectiveness and Safety of Subcutaneous Rituximab for Patients With Gastric MALT Lymphoma: A Case-Control Comparison With Intravenous Rituximab.
Rotkopf H, Lévy M, Copie-Bergman C, Dupuis J, Verlinde-Carvalho M, Itti E, Gagniere C, Belhadj K, Tannoury J, Le Bras F, Sobhani I, Haioun C, Amiot A. Rotkopf H, et al. Among authors: le bras f. Clin Lymphoma Myeloma Leuk. 2021 Jan;21(1):e32-e38. doi: 10.1016/j.clml.2020.08.014. Epub 2020 Aug 24. Clin Lymphoma Myeloma Leuk. 2021. PMID: 32921592
Daratumumab is safe and induces a rapid hematological response in light-chain amyloidosis with severe cardiac impairment.
Gounot R, Le Bras F, Dupuis J, Oghina S, Bodez D, Roulin L, Maarek A, Ladaique A, Beldi-Ferchiou A, Poullot E, Molinier-Frenkel V, Haioun C, Damy T, Belhadj K, Lemonnier F. Gounot R, et al. Among authors: le bras f. Leuk Lymphoma. 2021 Apr;62(4):979-983. doi: 10.1080/10428194.2020.1850717. Epub 2020 Nov 29. Leuk Lymphoma. 2021. PMID: 33251891 No abstract available.
Anti-SARS-CoV-2 antibody response after 2 and 3 doses of BNT162b2 mRNA vaccine in patients with lymphoid malignancies.
Gressens SB, Fourati S, Le Bouter A, Le Bras F, Dupuis J, Hammoud M, El Gnaoui T, Gounot R, Roulin L, Belhadj K, Haioun C, Gallien S, Melica G, Lemonnier F. Gressens SB, et al. Among authors: le bouter a, le bras f. Clin Microbiol Infect. 2022 Jun;28(6):885.e7-885.e11. doi: 10.1016/j.cmi.2022.02.029. Epub 2022 Mar 5. Clin Microbiol Infect. 2022. PMID: 35259530 Free PMC article.
72 results